Our company is led by:
- Chris Farina, Chief Executive Officer
- Jan Nilsson, Chief Scientific Officer
- Kevin Melvin, Vice President of Clinical Operations
- Ryan Abbott, General Counsel
Orticumab featured in Cardiovascular Business post on AI and inflammation. Read the Article.
Our company is led by: